Mount Sinai Innovation Partners (MSIP), the commercialization arm of the Mount Sinai Health System in New York, New York, has announced the creation of i3 Prism, a technology commercialization fund aimed at women and Black, Indigenous, and People of Color (BIPOC) health care innovators.
This one-of-a-kind opportunity allows a diverse group of innovators, including Mount Sinai faculty, staff, and students, to contribute to the advancement of innovations and the development of commercialization strategies. In order to bring inventions to life and improve health and well-being for all people, participating innovators can win up to $33,000 in financing based on their work’s milestone successes.
MSIP and its collaborators want to make it easier for Mount Sinai inventors to get funding, regardless of their discipline, and the fund is open to all teams within the Health System. Prism i3
